BioLight Life Sciences (XTAE:BOLT) EBIT per Share : ₪-5.89 (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is BioLight Life Sciences EBIT per Share?

BioLight Life Sciences's EBIT per Share for the six months ended in Dec. 2023 was ₪-4.62. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-5.89.

During the past 3 years, the average EBIT per Share Growth Rate was 2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for BioLight Life Sciences's EBIT per Share or its related term are showing as below:

XTAE:BOLT' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 0.8 Med: 32.4 Max: 71.7
Current: 2.8

During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of BioLight Life Sciences was 71.70% per year. The lowest was 0.80% per year. And the median was 32.40% per year.

XTAE:BOLT's 3-Year EBIT Growth Rate is ranked worse than
50.72% of 1311 companies
in the Biotechnology industry
Industry Median: 3.5 vs XTAE:BOLT: 2.80

BioLight Life Sciences's EBIT for the six months ended in Dec. 2023 was ₪-21.52 Mil.

BioLight Life Sciences EBIT per Share Historical Data

The historical data trend for BioLight Life Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences EBIT per Share Chart

BioLight Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-3.16

-3.09

-0.41

-1.89

-5.90

BioLight Life Sciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.79	-1.09	-0.79	-1.27	-4.62

BioLight Life Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

BioLight Life Sciences's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-27.41	/	4.644
=	-5.90

BioLight Life Sciences's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-21.523	/	4.656
=	-4.62

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪-5.89

BioLight Life Sciences (XTAE:BOLT) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

BioLight Life Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLight Life Sciences (XTAE:BOLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (XTAE:BOLT) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kiryat Atidim, Building 7, Entrance 1, 2nd Floor, Tel-Aviv, ISR, 6158101

Website

http://www.bio-light.co.il

BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.